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Seeing the world through different
lenses: activity registration differs
between two validated accelerometers
To the Editor:
Encouragement of regular physical activity is a cornerstone in the treatment of COPD [1], since physical
inactivity leads to increased mortality and hospitalisation rates [2, 3]. Additionally, regular physical activity
has shown a protective effect on lung function decline in subgroups [4].
Accurate measurement of the regular physical activity level is key for setting up patient-tailored physical
activity coaching programmes and the assessment of interventions. Wearable devices are frequently used to
assess physical activity levels and, in daily practice, triaxial monitors are the most reliable devices to
measure physical activity. The PROactive consortium showed that the Actigraph GT3X (Actigraph LLC,
Pensacola, FL, USA) and DynaPort MoveMonitor (McRoberts BV, The Hague, the Netherlands) are the
most valid accelerometers to estimate energy expenditure and discriminate between different walking
speeds in patients with COPD [5, 6]. Although strong correlations for both accelerometers with
activity-related energy expenditure (AEE) have been shown, data are lacking with regard to time spent in
physical activity or postures, such as walking and sitting.
Currently, the effects of pulmonary rehabilitation in patients with severe COPD who undergo
bronchoscopic lung volume reduction with endobronchial valves are studied (SoLVE study;
NCT03474471). Prior to the start of the SoLVE study, we noticed disproportional high non-worn times in
our Actigraph measurements. To select the most appropriate device for our study, we aimed to investigate
whether or not there were differences in non-worn time and type of activity registration between the
Actigraph GT3X and Dynaport MoveMonitor in the first 10 participants of our study. The SoLVE study
was approved by our local medical ethics committee and all patients signed informed consent.
Participants wore both accelerometers simultaneously for seven consecutive days and were instructed to
register the non-worn time in a diary. The Actigraph GT3X was worn on the right waist and the
DynaPort MoveMonitor on the lower back according to their instructions for use. In one patient, the
Actigraph GT3X measurement could not be analysed due to technical problems. Therefore, analyses were
performed on the results of nine patients (age: 64 yrs, male: 55.6%, forced expiratory volume in 1 s: 28%).
One patient took off both accelerometers overnight because of sleeping problems and therefore has a
substantial lower lying time and higher non-worn time. Wilcoxon signed rank tests were performed to
measure differences between both accelerometers. Two-way mixed intraclass correlation coefficients were
calculated to determine consistency between the Actigraph GT3X and DynaPort MoveMonitor
measurements. A comparison of the results of both accelerometers is given in table 1.
In comparison with the DynaPort MoveMonitor, the Actigraph GT3X registered significantly lower lying
time and AEE, and significantly higher standing and non-worn time. The DynaPort MoveMonitor derived
information about activities such as shuffling, walking, stair walking and cycling, whereas locomotion time
is not specifically registered by the Actigraph GT3X.
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Although the Actigraph GT3X registered a significantly higher standing time in comparison with the
DynaPort MoveMonitor, there was no significant difference between the Actigraph GT3X standing time
and the sum of the Dynaport MoveMonitor standing and locomotion time. It can therefore be
hypothesised that the Actigraph GT3X registers locomotion time as standing time.
The Actigraph GT3X registered a lower number of steps per day than the Dynaport MoveMonitor, but
this was not statistically significant and the intraclass correlation coefficients were good between both
measurements (absolute=0.76, consistency=0.80). A Bland–Altman plot was in agreement with these
findings.
The AEE was significantly different between both devices and the intraclass correlation coefficients were
poor (absolute=0.35, consistency=0.35). The Bland–Altman plot was in agreement with these findings. The
lower AEE estimate of the Actigraph GT3X could possibly be explained by the high non-worn time. The
Actigraph GT3X registered non-worn time was significantly higher than the diary registered non-worn
time, whereas there was no significant difference between the diary and the by DynaPort MoveMonitor
registered non-worn time. Given the disproportionally low lying time (10.6%) registered by the Actigraph
GT3X, it seems reasonable to assume that most lying time is registered as non-worn time. However,
non-worn time was also often registered throughout the day, even after correction of registration conflicts.
In conclusion, we found that two validated accelerometers showed significant differences in non-worn
time and type of activity registration in our small sample of patients with COPD. The technical field in
medicine is fast evolving and we tend to rely on validated instruments. Accelerometers are gaining
importance in research, clinical practice, and disease and health management. Although both
accelerometers are extensively validated against doubly labelled water [5], we recommend that the choice
of accelerometer should be based on the physical activity outcome of interest. Based on our data, we
decided to use the DynaPort MoveMonitor for our study given our interest in daily physical activity rather
than energy expenditure and the concerning high non-worn times as registered by the ActiGraph GT3X.
However, further research is warranted to validate type of activity registration of triaxial accelerometers in
patients with COPD.
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TABLE 1 Comparison of the results of the Actigraph GT3X and DynaPort MoveMonitor
Actigraph GT3X DynaPort MoveMonitor Median difference p-value
Steps per day 1761 (787–2905) 2446 (821–3914) 421 (−517–1183) 0.110
Activity-related energy
expenditure per day kcal
86 (43–139) 424 (357–704) 356 (279–579) 0.008
Lying time % 10.6 (1.3–37.7) 39.7 (6.0–58.0) 30.3 (4.7–39.4) 0.008
Sitting time % 44.1 (17.4–54.1) 43.7 (36.8–51.0) 0.4 (−5.1–19.4) 0.594
Standing time % 11.6 (4.1–30.8) 7.2 (3.0–18.0) 3.6 (−1.2–17.3) 0.015
Locomotion time % 3.2 (1.1–6.1) 1.0 (−2.8–13.2) 0.214
Non-worn time % 32.1 (10.7–44.8) 0.4 (0–40.7) 30.7 (1.7–43.7) 0.008
Non-worn time diary % 0.3 (0–41.3)# 0.3 (0–41.3)
Data are presented as median (range), unless otherwise stated. #: statistically significant different
compared with the accelerometer registered non-worn time.
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